Kathleen Evans, as Conservator of Jessica Evans, a Protected Person v. Lederle Laboratories, Link Clinic, and O. Sharma

167 F.3d 1106, 1999 U.S. App. LEXIS 1446, 1999 WL 44841
CourtCourt of Appeals for the Seventh Circuit
DecidedFebruary 3, 1999
Docket98-1293
StatusPublished
Cited by33 cases

This text of 167 F.3d 1106 (Kathleen Evans, as Conservator of Jessica Evans, a Protected Person v. Lederle Laboratories, Link Clinic, and O. Sharma) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kathleen Evans, as Conservator of Jessica Evans, a Protected Person v. Lederle Laboratories, Link Clinic, and O. Sharma, 167 F.3d 1106, 1999 U.S. App. LEXIS 1446, 1999 WL 44841 (7th Cir. 1999).

Opinion

CUDAHY, Circuit Judge.

During the first year of her life, Jessica Evans received three doses of a diphtheria, *1108 pertussis and tetanus (DPT) vaccine manufactured by Lederle and administered by Sharma, a physician, at the Link Clinic. Several years later, Jessica’s mother, Kathleen Evans, filed suit on her behalf seeking to recover damages for injuries allegedly caused by the vaccine. A confusing chronology of litigation ensued culminating in this appeal.

On August 14, 1985, Evans sued the Link Clinic and Sharma in state court. That action was voluntarily dismissed without prejudice to make way for a diversity action filed in the district court on June 8, 1990, naming as defendants Lederle, the Link Clinic and Sharma. On October 1, 1990, Evans filed suit in the Court of Claims seeking an award under the National Childhood Vaccine Injury Act (the “Vaccine Act”), 42 U.S.C. § 300aa-l et seq. That filing necessitated the voluntary dismissal of the pending diversity action. When the Court of Claims subsequently dismissed the Vaccine Act claim with prejudice, Evans went back to the district court and refiled the diversity action on February 28, 1995. The Link Clinic and Sharma moved to dismiss the claims against them pursuant to the Illinois saving statute which allows a plaintiff just one opportunity to refile an action that has been voluntarily dismissed. See 735 ILCS 5/13-217. The magistrate judge determined that the Illinois rule was preempted by the Vaccine Act and recommended that Evans be allowed to proceed with her action. But the district court rejected the magistrate judge’s recommendation on the ground that the Illinois rule was not preempted. Applying the Illinois rule, the court dismissed the Link Clinic and Shar-ma from the case and subsequently granted Lederle’s motion for judgment on the pleadings. We affirm.

I.

We review de novo the district court’s decision to dismiss the Link Clinic and Sharma as defendants. A motion to dismiss is granted only if “it appears beyond doubt that the plaintiff can prove no facts sufficient to support [her] claim for relief, and the facts in the complaint are viewed in the light most favorable to the non-moving party.” Flenner v. Sheahan, 107 F.3d 459, 461 (7th Cir.1997); see also City Nat. Bank of Florida v. Checkers, Simon & Rosner, 32 F.3d 277, 281 (7th Cir.1994). A motion for judgment on the pleadings is reviewed under the same standard as a motion to dismiss. See Flenner, 107 F.3d at 461; Frey v. Bank One, 91 F.3d 45, 46 (7th Cir.1996), cert. denied, 519 U.S. 1113, 117 S.Ct. 954, 136 L.Ed.2d 841 (1997). Thus, we also review the district court’s decision to enter judgment on the pleadings in favor of Lederle de novo applying the same principles.

The Vaccine Act provides a no-fault compensation system for individuals harmed by childhood vaccines. The system involves a special procedure whereby a vaccine-injury plaintiff files a petition in the Court of Claims, naming the Secretary of Health and Human Services as respondent, seeking an award to be administered from a fund financed by a tax on vaccines. See 42 U.S.C. § 300aa-ll et seq. Recourse to the Court of Claims is mandatory as a general rule. See 42 U.S.C. § 300aa-ll(a)(2)(A). However, a plaintiff, such as Evans, who was already in the throes of civil litigation when the Act came into effect was permitted but was not required to dismiss her civil action and bring a compensation claim under the Act. 1 See Amendola v. Secretary, Dept. Health & Human Serv., 989 F.2d 1180, 1184 (Fed.Cir.1993) (explaining the effect of the Act on pending litigation).

A curious feature of the Act is that filing a petition in the Court of Claims — whether mandatory or optional — does not signal the abandonment of traditional tort rights. Once proceedings in the Court of Claims have run their course, the vaccine-injury plaintiff is allowed to jump ship and initiate or resume a civil action. 2 Congress thus created a bias in *1109 favor of the federal compensation scheme by requiring vaccine-injury plaintiffs to exhaust the remedy under the Act before resorting to civil litigation. The result is “a new remedial system that interacts in a complicated way with traditional tort lawsuits.” Schafer v. American Cyanamid Co., 20 F.3d 1, 3 (1st Cir.1994). It is in sync with this pas de deux between Vaccine Act claims and conventional lawsuits that we must hop in deciding this appeal.

Evans’s original diversity action was pending in the district court when the Vaccine Act came into effect. She exercised her option to proceed under the Act and, having voluntarily dismissed the diversity action, filed a petition in the Court of Claims on October 1, 1990. The petition was dismissed' with prejudice pursuant to a joint stipulation. 3 Evans then elected to return to the district court and filed the present diversity action. 4 She advances two principal arguments — essentially a reiteration of the magistrate judge’s view — in support of her bid to maintain that action. First, Evans contends that the Illinois saving statute is preempted by the Vaccine Act and therefore cannot operate to bar her suit. Alternatively, Evans argues that the refiling of her diversity action does not offend the Illinois rule.

II.

In determining whether a federal statute preempts state law, “our ultimate task is to ascertain the intent of Congress.” American Agric. Movement, Inc. v. Board of Trade, 977 F.2d 1147, 1154 (7th Cir.1992). We have noted that the Act restricts but does not eliminate the exercise of traditional tort rights. In fact, the Act not only recognizes the possibility of civil actions but goes a step further and declares that “[sjtate law shall apply to a civil action brought for damages for a vaccine-related injury or death.” 42 U.S.C. § 300aa-22(a). Nevertheless, Evans contends that Congress expressly preempted the Illinois saving statute by virtue of the following provision:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Fadavi v. Ginn
N.D. Indiana, 2025
Jaimes v. Cook County
N.D. Illinois, 2019
Bell v. Cook County
N.D. Illinois, 2018
Peter T. Dvorak v. Granite Creek GP Flexcap I
908 F.3d 248 (Seventh Circuit, 2018)
Parungao v. Community Health Systems, Inc.
192 F. Supp. 3d 935 (N.D. Illinois, 2016)
Doe 52 v. Mayo Clinic Health System-Eau Claire Clinic, Inc.
98 F. Supp. 3d 989 (W.D. Wisconsin, 2015)
Veatch v. Bartels Lutheran Home
804 N.W.2d 530 (Court of Appeals of Iowa, 2011)
Kremers v. Coca-Cola Co.
712 F. Supp. 2d 759 (S.D. Illinois, 2010)
Forst v. SmithKline Beecham Corp.
602 F. Supp. 2d 960 (E.D. Wisconsin, 2009)
Muhammad v. Oliver
547 F.3d 874 (Seventh Circuit, 2008)
Andrews v. Chevy Chase Bank
545 F.3d 570 (Seventh Circuit, 2008)
Jackson v. Kotter
541 F.3d 688 (Seventh Circuit, 2008)
Boeckman v. A.G. Edwards, Inc.
461 F. Supp. 2d 801 (S.D. Illinois, 2006)
Syscon, Inc. v. Vehicle Valuation Services, Inc.
274 F. Supp. 2d 975 (N.D. Illinois, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
167 F.3d 1106, 1999 U.S. App. LEXIS 1446, 1999 WL 44841, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kathleen-evans-as-conservator-of-jessica-evans-a-protected-person-v-ca7-1999.